Published in Am J Kidney Dis on July 01, 2000
Availability, utilization and outcomes of deceased diabetic donor kidneys; analysis based on the UNOS registry. Am J Transplant (2012) 1.52
Influence of Deceased Donor and Pretransplant Recipient Parameters on Early Overall Kidney Graft-Survival in Germany. J Transplant (2015) 0.78
Donor Heart Utilization following Cardiopulmonary Arrest and Resuscitation: Influence of Donor Characteristics and Wait Times in Transplant Regions. J Transplant (2014) 0.75
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69
Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant (2006) 8.03
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis (1998) 7.79
Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (1998) 5.28
Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol (2001) 4.36
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet (1999) 4.04
The problems of drug-resistant pathogenic bacteria. Regulation of R-factor replication in Proteus mirabilis. Ann N Y Acad Sci (1971) 3.81
Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med (1989) 3.67
Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int (2006) 3.58
The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant (2010) 3.35
Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA (1993) 3.10
Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis (1999) 3.09
Report of a National Conference on Donation after cardiac death. Am J Transplant (2006) 3.04
Delayed graft function: risk factors and implications for renal allograft survival. Transplantation (1997) 3.01
Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr (2002) 2.96
Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2001) 2.94
Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int (2001) 2.92
Median sensory distal amplitude and latency: comparisons between nonexposed managerial/professional employees and industrial workers. Am J Ind Med (1993) 2.87
Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int (2006) 2.85
Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol (2001) 2.80
Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis (2000) 2.65
Effect of waiting time on renal transplant outcome. Kidney Int (2000) 2.57
The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA (1993) 2.54
Calculating life years from transplant (LYFT): methods for kidney and kidney-pancreas candidates. Am J Transplant (2008) 2.39
Long-term survival in renal transplant recipients with graft function. Kidney Int (2000) 2.38
Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion. Am J Transplant (2008) 2.38
Occupational and other exposures associated with male end-stage renal disease: a case/control study. Am J Public Health (1990) 2.26
Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant (2006) 2.22
Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin Pharmacol Ther (1997) 2.17
Noncompliance in hemodialysis: predictors and survival analysis. Am J Kidney Dis (1998) 2.16
Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol (2000) 2.16
Analytical methods and database design: implications for transplant researchers, 2005. Am J Transplant (2006) 2.14
Predictors of type of vascular access in hemodialysis patients. JAMA (1996) 2.00
Survival advantage in Asian American end-stage renal disease patients. Kidney Int (1999) 1.98
Mortality after kidney transplantation: a comparison between the United States and Canada. Am J Transplant (2006) 1.92
Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation (2000) 1.90
Racial and gender variation in use of diagnostic colonic procedures in the Michigan Medicare population. Med Care (1999) 1.82
Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest (1989) 1.82
The dose of hemodialysis and patient mortality. Kidney Int (1996) 1.82
Effects of age, sex, and anthropometric factors on nerve conduction measures. Muscle Nerve (1992) 1.80
Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis (1998) 1.78
Geographic variability in access to primary kidney transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.77
Socioeconomic status and end-stage renal disease in the United States. Kidney Int (1994) 1.75
The impact of vascular access for haemodialysis on patient morbidity and mortality. Nephrol Dial Transplant (1997) 1.73
ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int (1996) 1.71
Recovery and utilization of deceased donor kidneys from small pediatric donors. Am J Transplant (2006) 1.68
Differences in access to cadaveric renal transplantation in the United States. Am J Kidney Dis (2000) 1.67
Use of community versus individual socioeconomic data in predicting variation in hospital use. Health Serv Res (1998) 1.64
Geographic differences in event rates by model for end-stage liver disease score. Am J Transplant (2006) 1.62
The effect of bystander CPR on survival of out-of-hospital cardiac arrest victims. Am Heart J (1985) 1.61
Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant (2001) 1.60
Randomized controlled trial of hand-assisted laparoscopic versus open surgical live donor nephrectomy. Transplantation (2001) 1.58
Cryptic B cell response to renal transplantation. Am J Transplant (2013) 1.57
Extracorporeal support: improves donor renal graft function after cardiac death. Am J Transplant (2010) 1.56
Geographic variation in end-stage renal disease incidence and access to deceased donor kidney transplantation. Am J Transplant (2010) 1.55
Dynamic challenges inhibiting optimal adoption of kidney paired donation: findings of a consensus conference. Am J Transplant (2013) 1.55
CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size. Br J Radiol (2000) 1.55
Renal transplantation in children with severe lower urinary tract dysfunction. J Urol (1999) 1.51
Effect of race on access to recombinant human erythropoietin in long-term hemodialysis patients. JAMA (1994) 1.51
Repeat organ transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.50
Body size, dose of hemodialysis, and mortality. Am J Kidney Dis (2000) 1.48
Evaluation of living renal donors. The current practice of US transplant centers. Transplantation (1995) 1.47
The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation (2001) 1.46
Utilization of kidneys with similar kidney donor risk index values from standard versus expanded criteria donors. Am J Transplant (2012) 1.46
Patterns of low incidence of treated end-stage renal disease among the elderly. Am J Kidney Dis (1992) 1.45